Effects of Erand mul arka eye drop on simple allergic conjunctivitis.

Randomized controlled trial of Eranad mul arka eye drop with Olopetadine 0.1% eye drop in Vataj Abhishand W.S.R simple allergic conjunctivitis.

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/05/042345

Enrollment

Registered

2022-05-02

Start date

Unknown

Completion date

Unknown

Last updated

2022-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H103- Unspecified acute conjunctivitis

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1) Both male and female 2) Between the age group of 18 to 60 yrs will be included in the study. 3) Patient suffering from Toda (pricking pain), Sangharsh (foreign body sensation), Vishushk Bhav (dryness feeling), Shishirasruta (cline/watery discharge), Alpashopha (mild chemosis) will be selected irrespective of their sex, education, socio economic status & religion.

Exclusion criteria

Exclusion criteria: 1) Patient not willing for trial 2) Pregnant & lactating women. 3) Patient who need surgical and other in intervention.

Design outcomes

Primary

Measure	Time frame
to see effect of Erand Mul Arka Eye drop and Olopetadine 0.1 % Eye drop in Vataj Abhi Shyand (simple allergic conjunctivitis) To review ancient literature on Vataj Abhi Shyand (simple allergic conjunctivitis) Timepoint: 7th and 15th days	—

Secondary

Measure	Time frame
evidence base support for the effect of Erand Mul Eye Drop as mentioned in our ancient literature provide simple and effective treatment for Vataj Abhi Shyand (simple allergic conjunctivitis) Timepoint: throught study for 15 days	—

Countries

India

Contacts

Public ContactVivek P Harne

Dr D Y Patil College Of Ayurveda And Research Center

pallavibhor78@gmail.com8983535924

Outcome results